Schroder Investment Management Group Bei Gene, Ltd. Transaction History

Schroder Investment Management Group

$101 Billion
Q4 2024

A detailed history of Schroder Investment Management Group transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Schroder Investment Management Group holds 86,329 shares of BGNE stock, worth $19.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

86,329

Previous 32,299 167.28%

Holding current value

$19.6 Million

Previous $7.25 Million 119.9%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$174.72 - $246.04 $9.44 Million - $13.3 Million	54,030 Added 167.28%	86,329 $15.9 Million
Q3 2024 Nov 13, 2024	SELL	$143.93 - $224.51 $7.48 Million - $11.7 Million	-51,989 Reduced 61.68%	32,299 $7.25 Million
Q2 2024 Aug 12, 2024	BUY	$129.52 - $174.32 $1.35 Million - $1.82 Million	10,427 Added 14.12%	84,288 $12 Million
Q1 2024 May 14, 2024	BUY	$141.8 - $181.47 $8.67 Million - $11.1 Million	61,161 Added 481.58%	73,861 $11.6 Million
Q4 2023 Feb 13, 2024	BUY	$158.67 - $201.58 $2.02 Million - $2.56 Million	12,700 New	12,700 $2.29 Million
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $39,999 - $73,589	-273 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $68,602 - $107,457	-276 Reduced 50.27%	273 $6,000
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $126,547 - $204,391	507 Added 1207.14%	549 $15,000
Q2 2021 Aug 13, 2021	SELL	$292.75 - $367.01 $877,371 - $1.1 Million	-2,997 Reduced 98.62%	42 $14,000
Q1 2021 May 17, 2021	BUY	$260.64 - $382.12 $792,084 - $1.16 Million	3,039 New	3,039 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $32,089 - $45,908	-145 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $27,431 - $41,533	145 New	145 $41,000
Q2 2020 Aug 13, 2020	SELL	$123.9 - $195.41 $10,283 - $16,219	-83 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $10,112 - $14,374	83 New	83 $12,000
Q2 2018 Aug 13, 2018	SELL	$152.5 - $216.77 $427,000 - $606,956	-2,800 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $272,748 - $496,216	2,800 New	2,800 $470,000

Others Institutions Holding BGNE

# of Institutions

251

Shares Held

45.6M

Call Options Held

322K

Put Options Held

144K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Bei Gene, Ltd. Transaction History